449 related articles for article (PubMed ID: 28938092)
1. CTCF-Mediated Enhancer-Promoter Interaction Is a Critical Regulator of Cell-to-Cell Variation of Gene Expression.
Ren G; Jin W; Cui K; Rodrigez J; Hu G; Zhang Z; Larson DR; Zhao K
Mol Cell; 2017 Sep; 67(6):1049-1058.e6. PubMed ID: 28938092
[TBL] [Abstract][Full Text] [Related]
2. The BET Protein BRD2 Cooperates with CTCF to Enforce Transcriptional and Architectural Boundaries.
Hsu SC; Gilgenast TG; Bartman CR; Edwards CR; Stonestrom AJ; Huang P; Emerson DJ; Evans P; Werner MT; Keller CA; Giardine B; Hardison RC; Raj A; Phillips-Cremins JE; Blobel GA
Mol Cell; 2017 Apr; 66(1):102-116.e7. PubMed ID: 28388437
[TBL] [Abstract][Full Text] [Related]
3. Functional assessment of CTCF sites at cytokine-sensing mammary enhancers using CRISPR/Cas9 gene editing in mice.
Lee HK; Willi M; Wang C; Yang CM; Smith HE; Liu C; Hennighausen L
Nucleic Acids Res; 2017 May; 45(8):4606-4618. PubMed ID: 28334928
[TBL] [Abstract][Full Text] [Related]
4. CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.
Eldholm V; Haugen A; Zienolddiny S
Int J Cancer; 2014 May; 134(10):2305-13. PubMed ID: 24174344
[TBL] [Abstract][Full Text] [Related]
5. Promoter-proximal CTCF binding promotes distal enhancer-dependent gene activation.
Kubo N; Ishii H; Xiong X; Bianco S; Meitinger F; Hu R; Hocker JD; Conte M; Gorkin D; Yu M; Li B; Dixon JR; Hu M; Nicodemi M; Zhao H; Ren B
Nat Struct Mol Biol; 2021 Feb; 28(2):152-161. PubMed ID: 33398174
[TBL] [Abstract][Full Text] [Related]
6. CTCF fences make good neighbours.
Krivega I; Dean A
Nat Cell Biol; 2017 Jul; 19(8):883-885. PubMed ID: 28752854
[TBL] [Abstract][Full Text] [Related]
7. YY1 Is a Structural Regulator of Enhancer-Promoter Loops.
Weintraub AS; Li CH; Zamudio AV; Sigova AA; Hannett NM; Day DS; Abraham BJ; Cohen MA; Nabet B; Buckley DL; Guo YE; Hnisz D; Jaenisch R; Bradner JE; Gray NS; Young RA
Cell; 2017 Dec; 171(7):1573-1588.e28. PubMed ID: 29224777
[TBL] [Abstract][Full Text] [Related]
8. ZNF143 mediates CTCF-bound promoter-enhancer loops required for murine hematopoietic stem and progenitor cell function.
Zhou Q; Yu M; Tirado-Magallanes R; Li B; Kong L; Guo M; Tan ZH; Lee S; Chai L; Numata A; Benoukraf T; Fullwood MJ; Osato M; Ren B; Tenen DG
Nat Commun; 2021 Jan; 12(1):43. PubMed ID: 33397967
[TBL] [Abstract][Full Text] [Related]
9. Facultative CTCF sites moderate mammary super-enhancer activity and regulate juxtaposed gene in non-mammary cells.
Willi M; Yoo KH; Reinisch F; Kuhns TM; Lee HK; Wang C; Hennighausen L
Nat Commun; 2017 Jul; 8():16069. PubMed ID: 28714474
[TBL] [Abstract][Full Text] [Related]
10. Dynamic CTCF binding directly mediates interactions among cis-regulatory elements essential for hematopoiesis.
Qi Q; Cheng L; Tang X; He Y; Li Y; Yee T; Shrestha D; Feng R; Xu P; Zhou X; Pruett-Miller S; Hardison RC; Weiss MJ; Cheng Y
Blood; 2021 Mar; 137(10):1327-1339. PubMed ID: 33512425
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional genome architectural CCCTC-binding factor makes choice in duplicated enhancers at Pcdhα locus.
Wu Y; Jia Z; Ge X; Wu Q
Sci China Life Sci; 2020 Jun; 63(6):835-844. PubMed ID: 32249388
[TBL] [Abstract][Full Text] [Related]
12. CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression.
Zhao X; Li D; Pu J; Mei H; Yang D; Xiang X; Qu H; Huang K; Zheng L; Tong Q
Oncogene; 2016 Jul; 35(27):3565-76. PubMed ID: 26549029
[TBL] [Abstract][Full Text] [Related]
13. CTCF shapes chromatin structure and gene expression in health and disease.
Dehingia B; Milewska M; Janowski M; Pękowska A
EMBO Rep; 2022 Sep; 23(9):e55146. PubMed ID: 35993175
[TBL] [Abstract][Full Text] [Related]
14. Dynamic Long-Range Chromatin Interaction Controls Expression of IL-21 in CD4+ T Cells.
Park JH; Choi Y; Song MJ; Park K; Lee JJ; Kim HP
J Immunol; 2016 May; 196(10):4378-89. PubMed ID: 27067007
[TBL] [Abstract][Full Text] [Related]
15. CTCF-mediated chromatin loops enclose inducible gene regulatory domains.
Oti M; Falck J; Huynen MA; Zhou H
BMC Genomics; 2016 Mar; 17():252. PubMed ID: 27004515
[TBL] [Abstract][Full Text] [Related]
16. CTCF modulates Estrogen Receptor function through specific chromatin and nuclear matrix interactions.
Fiorito E; Sharma Y; Gilfillan S; Wang S; Singh SK; Satheesh SV; Katika MR; Urbanucci A; Thiede B; Mills IG; Hurtado A
Nucleic Acids Res; 2016 Dec; 44(22):10588-10602. PubMed ID: 27638884
[TBL] [Abstract][Full Text] [Related]
17. Alteration of CTCF-associated chromatin neighborhood inhibits TAL1-driven oncogenic transcription program and leukemogenesis.
Li Y; Liao Z; Luo H; Benyoucef A; Kang Y; Lai Q; Dovat S; Miller B; Chepelev I; Li Y; Zhao K; Brand M; Huang S
Nucleic Acids Res; 2020 Apr; 48(6):3119-3133. PubMed ID: 32086528
[TBL] [Abstract][Full Text] [Related]
18. Enhancer-blocking activity is associated with hypersensitive site V sequences in the human growth hormone locus control region.
Jin Y; Oomah K; Cattini PA
DNA Cell Biol; 2011 Dec; 30(12):995-1005. PubMed ID: 21711161
[TBL] [Abstract][Full Text] [Related]
19. DNA fragments binding CTCF in vitro and in vivo are capable of blocking enhancer activity.
Didych DA; Kotova ES; Akopov SB; Nikolaev LG; Sverdlov ED
BMC Res Notes; 2012 Apr; 5():178. PubMed ID: 22480385
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional Dysregulation of MYC Reveals Common Enhancer-Docking Mechanism.
Schuijers J; Manteiga JC; Weintraub AS; Day DS; Zamudio AV; Hnisz D; Lee TI; Young RA
Cell Rep; 2018 Apr; 23(2):349-360. PubMed ID: 29641996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
